StockData
Zoetis Inc. logo

Zoetis Inc. (ZTS) stock

ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3045% below fair value
$83.82+0.86 (+1.04%)

Close on Nov 13, 2026Market cap $34.64BP/E 14.1Yield 2.42%

Zoetis enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Zoetis's enterprise value was $41.57B on Nov 11, 2026, against $61.39B a year earlier. Over the last 5 years it ranged from $36.29B to $118.84B, with a median of $80.01B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$41.57B-31.1%
2025Dec 31, 2025$60.34B-23.1%
2024Dec 31, 2024$78.43B-17.9%
2023Dec 29, 2023$95.49B+31.9%
2022Dec 30, 2022$72.41B-39.1%
2021Dec 31, 2021$118.84B+43.7%
2020Dec 31, 2020$82.70B+22.1%
2019Dec 31, 2019$67.72B+46.6%
2018Dec 31, 2018$46.19B+18.8%
2017Dec 29, 2017$38.89B+28.4%
2016Dec 30, 2016$30.29B+14.1%
2015Dec 31, 2015$26.55B+7.7%
2014Dec 31, 2014$24.65B+25.5%
2013Dec 31, 2013$19.63B–

More Zoetis figures

See a number that looks wrong?